Neurim Pharmaceuticals is a drug discovery and development company. Its first approved drug, Circadin® – prolonged release melatonin for insomnia, has been commercially available in the EU since October, 2007
5 July 2010 Circadin is approved in the EU for treatment of Primary Insomnia in patients aged 55 or over for up to 3 months.
11 June 2009 Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients.
24 September 2007
